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Abstract 
The RBFOX1 gene (or A2BP1) encodes a splicing factor important for neuronal development that 
has been related to autism spectrum disorder and other neurodevelopmental phenotypes. Evidence 
from complementary sources suggests that this gene contributes to aggressive behavior. 
Suggestive associations with RBFOX1 have been identified in genome-wide association studies 
(GWAS) of anger, conduct disorder, and aggressive behavior. Nominal association signals in 
RBFOX1 were also found in an epigenome-wide association study (EWAS) of aggressive 
behavior. Also, variants in this gene affect temporal lobe volume, a brain area that is altered in 
several aggression-related phenotypes. In animals, this gene has been shown to modulate 
aggressive behavior in Drosophila. RBFOX1 has also been associated with canine aggression and 
is upregulated in mice that show increased aggression after frustration of an expected reward. 
Associated common genetic variants as well as rare duplications and deletions affecting RBFOX1 
have been identified in several psychiatric and neurodevelopmental disorders that are often 
comorbid with aggressive behaviors. In this paper, we comprehensively review the cumulative 
evidence linking RBFOX1 to aggression behavior and provide new results implicating RBFOX1 
in this phenotype. Most of these studies (genetic and epigenetic analyses in humans, neuroimaging 
genetics, gene expression and animal models) are hypothesis-free, which strengthens the validity 
of the findings, although all the evidence is nominal and should therefore be taken with caution. 
Further studies are required to clarify in detail the role of this gene in this complex phenotype. 
 
Introduction 
Aggressive behavior and violence are major causes of mortality and morbidity in humans. These 
traits are observed in several psychiatric and neurodevelopmental disorders. Aggressive behavior 
is an evolutionary conserved trait of high importance for species survival. For this reason, it has 
been subject to selection throughout evolution and has a substantial genetic underpinning, while 
staying responsive to environmental cues. Accordingly, the heritability of aggressive behaviors 
has been estimated to be around 50% (reviewed by Veroude et al. (2016)). Several genes and 
pathways contributing to aggression have been identified, such as those involved in the 
serotonergic and dopaminergic neurotransmission and in hormone regulation, although most of 
the genetic contribution to aggression is still unexplained (Fernàndez-Castillo and Cormand, 
2016). 
In a recent review on the genetics of human aggressive behavior, we searched for genes and 
pathways involved in this phenotype using data from genome-wide association studies (GWAS), 
which so far have not produced genome-wide significant genes/loci (Fernàndez-Castillo and 
Cormand, 2016). Among others, we highlighted the RBFOX1 gene (also known as A2BP1), which 
showed suggestive associations in three different GWAS (Anney et al., 2008; Mick et al., 2014; 
Sonuga-Barke et al., 2008). Interestingly, other complementary sources of evidence provide 
additional support for the contribution of this gene to the susceptibility to aggressive behavior and 
to several psychiatric disorders as well. RBFOX1 encodes the RNA Binding Protein, Fox-1 
Homolog 1, also known as Ataxin-2-binding protein. It is expressed mainly in the nervous system, 
heart, and muscle (Jin et al., 2003; Underwood et al., 2005). The gene encodes a splicing factor 
that plays an important role in the regulation of the alternative splicing of large neuronal gene 
networks important for brain development (Bill et al., 2013; Conboy, 2017; Li et al., 2015). 
Cytoplasmic and nuclear RBFOX1 isoforms seem to play different roles, with the first one 
contributing to mRNA stability and promoting translation and the second one acting as a splicing 
regulator (Hamada et al., 2016; Lee et al., 2016). The nuclear isoform is involved in neuron 
migration and synapse network formation during corticogenesis (Hamada et al., 2016) and is 
important for the control of neuronal excitation in the mammalian brain (Gehman et al., 2011). 
Alterations in the RBFOX1 gene have been associated with several neurodevelopmental 
pathologies, especially autism spectrum disorder (reviewed by Bill et al. (2013)). 
Here, we review the cumulative evidence supporting a contribution of RBFOX1 to aggressive 
behaviors and to other psychiatric and neurodevelopmental disorders that often display aggressive 
behavior. We also present hitherto unpublished data derived from genetic association and 
neuroimaging genetics studies supporting our hypothesis. 
 
2. RBFOX1 and aggressive behavior in humans 
2.1. Association studies 
In a previous review of the genetic basis of aggressive behavior in humans (Fernàndez-Castillo 
and Cormand, 2016), RBFOX1 showed suggestive associations (p < 5e −05, Table 1) with 
aggressive traits or diagnostic categories in three GWAS (Anney et al., 2008; Merjonen et al., 
2011; Sonuga-Barke et al., 2008). A common variant located within the first intron of the RBFOX1 
gene, rs6500744, was identified as one of the top association signals in a GWAS assessing gene 
by environment interactions (GxE) (Sonuga-Barke et al., 2008). The C allele of this single 
nucleotide polymorphism (SNP) was associated with conduct disorder (CD) symptoms in 
interaction with mothers’ warmth (Table 1 , Figure 1 ). Another SNP, also located in intron 1 of 
RBFOX1 , rs8062784, was associated with anger in a GWAS assessing hostility in adolescents and 
adults (Merjonen et al., 2011 ), and two variants located in intron 3 of the gene, rs10153149 and 
rs12921846, were associated with CD in a sample of ADHD trios (Anney et al., 2008) (see Table 
1 and Figure 1). 
 
 A meta-analysis of nine population-based GWASs including around 19,000 children provided 
more evidence for the contribution of RBFOX1 to aggressive behavior (Pappa et al., 2016). Four 
SNPs in this gene (rs809682, rs12922093, rs12373031, and rs10521042, all located in intron 2) 
showed suggestive associations with children’s aggressive behavior in a meta-analysis (p < 5e 
−04, Table 1 and Figure 1, data kindly provided by the authors). 
Overall, eight RBFOX1 variants from four GWASs showed a nominal association with aggression. 
The variants associated in each GWAS were not in linkage disequilibrium (LD) with those from 
the other studies. The LD between the four variants found associated in the meta-analysis (Pappa 
et al., 2016) was moderate to high. In an attempt to investigate the association of RBFOX1 with 
aggressive behavior further, we genotyped four SNPs (the most significant one from each GWAS) 
in a sample of German male prisoners, not included in any of the GWASs (n = 188, Supplementary 
material). A significant association was found for rs809682, when comparing aggressive prisoners 
to controls (p = 0.03, additive model) as well as aggressive prisoners to non-aggressive prisoners 
(p = 0.02), but not when comparing non-aggressive prisoners and controls (p = 0.76) 
(Supplementary Table 1). However, the direction of the effect was opposite as that of the original 
study, with the A allele linked to aggression (Supplementary Table 1 and Table 1). The same 
variant was also genotyped in a population-representative sample of 1176 individuals from the 
Estonian Children Personality Behaviour and Health Study, ECPBHS (Harro et al., 2001; Vaht et 
al., 2016) (see Supplementary material for details). Several traits related to aggressiveness were 
assessed in this population-based cohort, in particular those related to personality and anxiety. In 
the ECPBHS, five-factor personality data at young adulthood were available from the Estonian 
version of the NEO-PI-R questionnaire (Kallasmaa et al., 2000) and anxiety information from 
Spielberger’s Trait Anxiety questionnaire (Spielberger, 1983). Aggressiveness is associated with 
certain facets in basic personality traits, in particular with low agreeableness and neuroticism 
(Caprara et al., 1996; Sharpe and Desai, 2001), and is also associated with anxiety (Clement and 
Chapouthier, 1998; Siddaway et al., 2017; Van Praag, 1998), higher negative emotionality 
(Caprara et al., 1996; Kodžopeljić et al., 2014; Tremblay and Ewart, 2005), and lower extraversion 
levels (Sharpe and Desai, 2001; Tremblay and Ewart, 2005). In the Estonian sample, rs809682 
was nominally associated with extraversion (p = 0.024), the T/T homozygotes showing the lowest 
levels of extraversion (Supplementary Table 2). We recently showed that sex can influence the 
contribution of genes to aggression (van Donkelaar et al., under review). We therefore also 
investigated genotype by sex interactions. RBFOX1 genotype and sex indeed had a significant 
interaction effect on agreeableness (p = 6e −03); male T/T homozygotes had the lowest scores of 
agreeableness. While NEO-PI neuroticism was not significantly associated with the genotype, data 
on Spielberger’s Trait Anxiety showed a nominal association (p = 0.043), with the T-allele carriers 
having higher levels of anxiety. Findings in the Estonian sample are in the direction expected for 
a gene associated with aggression, and suggest that higher expression of aggressive behavior in 
the T-allele carriers of the RBFOX1 rs809682 polymorphism may be related to basic personality 
traits and anxiety. 
As indicated above, aggressive behavior is influenced by both genes and environment. For this 
reason, looking at epigenetic profiles linked to aggression also may provide insight into RBFOX1 
’s role. A recent epigenome-wide association study (EWAS) of aggressive behavior investigated 
DNA methylation levels associated with this phenotype in a sample of 2,029 individuals (van 
Dongen et al., 2015). This study did not produce any epigenome-wide significant findings, but two 
nominal associations between aggressive behavior and the methylation levels of sites located in 
RBFOX1 were identified at cg12310850 (GRCh37/hg19 position; chr16: 6,533,700, p = 8.7e −03) 
and cg00499781 (chr16: 7,568,364, p = 0.040) (data kindly provided by the authors). The authors 
also investigated the methylation levels of monozygotic twins highly discordant for aggression, 
identifying five nominal associations in sites located in RBFOX1 at cg03934713 (chr16: 6,069,198, 
p = 0.047), cg16396980 (chr16: 6,633,344, p = 0.041), cg06705265 (chr16: 6,696,222, p = 0.024), 
cg00514665 (chr16: 7,703,812, p = 0.049), and cg03986562 (chr16: 7,703,893, p = 0.037). 
 
2.2. Neuroimaging genetics studies and gene expression 
Human neuroimaging genetics studies suggest that the RBFOX1 gene contributes to brain function 
and structure. Thus, RBFOX1 has been shown to influence temporal lobe volume with genome-
wide significance in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) cohort including 
patients with Alzheimer’s disease, patients with mild cognitive impairment, and cognitively 
healthy elderly controls (Kohannim et al., 2012b). In a related genome-wide study on the ADNI 
cohort, Kohannim et al. (2012a) observed that a variant in the RBFOX1 gene was highly predictive 
of temporal brain volume. The association between a specific variant in RBFOX1 and temporal 
lobe structure has been confirmed in voxel-wise whole-brain analyses in the ADNI cohort 
(Kohannim et al., 2012a, 2012b). In line with these findings, the RBFOX1 gene has been identified 
as specifically contributing to grey matter loss in the temporal lobe in patients with mild cognitive 
impairment, in a sample of Alzheimer’s Disease (Vounou et al., 2012). While the aforementioned 
studies consistently show a link between RBFOX1 and temporal lobe volume at genome-wide 
significance, caution in drawing conclusions for healthy younger adults is required as all findings 
are based on the ADNI cohort studying associations between temporal lobe volume in older adults 
with and without cognitive impairment and manifesting Alzheimer’s disease. Thus, these 
associations between RBFOX1 and brain structure might be explained by the decline in temporal 
lobe volume observed in Alzheimer’s disease and mild cognitive impairment (e.g., Vounou et al., 
2012). Still, the link between RBFOX1 and temporal lobe volume is intriguing because 
Alzheimer’s disease often presents with aggressive behavior (Zhao et al., 2016). Moreover, animal 
and human studies have underlined the role of the temporal lobe for aggression, especially with 
the amygdala and hippocampus being located in its medial part (Gregg and Siegel, 2001; Potegal, 
2012; Siever, 2008). Abnormalities in temporal lobe function and structure have been observed in 
aggressive populations including individuals with conduct disorder (CD) (Cappadocia et al., 2009; 
Kruesi et al., 2004), psychopathy (Raine et al., 2004), and aggressive schizophrenia (Hoptman et 
al., 2011; Soyka, 2011). Structural and functional changes in the temporal lobe in aggressive 
populations may be related to impaired emotion regulation (Bufkin, 2005) and/or to the lack of 
empathy in CD and antisocial behavior (Cappadocia et al., 2009). Still, although RBFOX1 seems 
to contribute to temporal lobe functioning, that does not directly support its contribution to 
aggressive behavior and further studies should investigate the effect of these variants.  
In a recent study, we found the first evidence that the risk variant rs6500744 in the RBFOX1 gene, 
which had been associated with aggression in the GWAS of Sonuga-Barke et al. (2008) , might be 
relevant to brain activity during neurocognitive processes such as inhibitory control and emotional 
reactivity (Gan et al., in preparation). In a sample of 331 healthy human participants, carriers of 
the risk allele C (C/C and C/T) showed an increased brain response in the dorsal anterior cingulate 
cortex (ACC) during emotion processing, and reduced brain responses in the left inferior/middle 
frontal gyrus during inhibitory control measured with a combined Flanker/Go-Nogo task. 
Moreover, we observed a sex by SNP interaction, in which female C/Ccarriers showed increased 
and male C/C-carriers showed decreased responding in the fusiform face area and the 
hypothalamus/ventral striatum compared to T-allele carriers during a Hariri emotional face 
recognition task (for fMRI tasks, compare (Meyer-Lindenberg et al., 2006)). Importantly, these 
findings converge with neuroimaging phenotypes including impaired brain functioning in 
prefrontallimbic networks during inhibitory control and emotional reactivity in carriers of the 
MAOA-L genotype, the most widely studied risk genotype for aggression (Alia-Klein et al., 2011; 
Buckholtz and Meyer-Lindenberg, 2008; Fan et al., 2003; Meyer-Lindenberg et al., 2006; 
Passamonti et al., 2006). 
As expected, given its role in neurodevelopment, the expression of RBFOX1 in humans is mainly 
restricted to the brain, although it is also expressed in skeletal muscle and heart (Figure 2). 
Interestingly, the prefrontal cortex (PFC) including the anterior cingulate cortex (ACC) shows the 
highest RBFOX1 expression levels in humans (Figure 2). The PFC has been shown to play a role 
in impulsive aggression (Blair, 2016; Fan et al., 2003; Passamonti et al., 2006), most likely through 
its involvement in inhibitory control and behavioral self-regulation (Buckholtz and Meyer-
Lindenberg, 2008; Davidson et al., 2000; Heatherton and Wagner, 2011). Also, ACC impaired 
functioning and structural abnormalities of this area has been repeatedly linked to a propensity for 
impulsive/reactive aggression (Buckholtz and Meyer-Lindenberg, 2008; Meyer-Lindenberg et al., 
2006; Sterzer et al., 2005). Moreover, high expression levels of RBFOX1 are also found in the 
basal ganglia including the nucleus accumbens, putamen and caudate, brain areas previously 
linked to impulsive aggression across species (Buckholtz et al., 2010; Couppis and Kennedy, 2008; 
Ferrari et al., 2003; Gan et al., 2015; Krämer et al., 2007). A similar but less pronounced RBFOX1 
expression level emerges for the amygdala, a crucial brain area for impulsive reactive aggression 
due to its involvement in emotional reactivity to threatening cues (Buckholtz et al., 2008; Coccaro 
et al., 2007; Meyer-Lindenberg et al., 2006). To conclude, although the observation of high 
RBFOX1 expression in brain areas relevant to aggression is interesting, this fact does not 
necessarily link this gene with aggression, as many other genes may show similar expression 
patterns and also many brain regions are involved in aggressive behavior. Future imaging genetic 
studies may shed light on the impact of RBFOX1 genotypes and pathways on brain function and 
structure within these areas. 
 
 
3. RBFOX1 and aggressive behavior in animals 
RBFOX1, also known as A2BP1, has been related to aggressive behavior in animal models of 
aggression. In Drosophila , A2bp1 was one of the genes identified through a genomewide analysis 
aimed at mapping loci involved in aggressive behavior (Shorter et al., 2015). The study used the 
sequenced inbred lines of the Drosophila melanogaster Genetic Reference Panel (DGRP) to 
investigate natural genetic variation related to aggression. Male-to-male aggression was quantified 
in 200 DGRP lines to identify the underlying genetic variation. Extreme quantitative trait locus 
(QTL) genome-wide association analysis was also performed in a population derived from DGRP 
lines with extremely high and extremely low aggression scores. From both analyses, the authors 
obtained a genetic interaction network with 741 genes, in which A2bp1 was present as an important 
node. The functional validation of the finding for the A2bp1 gene, using a mutant line with a 
Mi{ET1} element insertional mutation, yielded significant evidence that homozygous mutant flies 
for this gene show decreased aggression (p < 0.001). 
In a genome-wide mapping study of aggression in dogs, several nominal associations with A2bp1 
were identified in two different cohorts (Zapata et al., 2016). Some of these signals in A2bp1 were 
associated with the four measures of aggression that were assessed: stranger-directed aggression 
(towards unfamiliar humans), dog-directed aggression (towards unfamiliar dogs), owner-directed 
aggression (towards familiar humans) and dog rivalry (towards familiar dogs). Four loci in A2bp1 
were nominally associated with all four measures in one cohort (chr6: 35,449,934, chr6: 
35,459,495, chr6: 35,557,330 and chr6: 35,557,812) and two in another cohort (chr6: 35,641,555 
and chr6: 35,672,733).  
Finally, in a murine model of frustration that showed increased aggressive behavior when the 
access to an expected reward was denied (Burokas et al., 2012), A2bp1 expression was upregulated 
(fold change = 1.32, p = 1.29e −03, FDR < 5%) in ventral striatum of frustrated mice (Martín-
García et al., 2015). 
Mutant animal models of Rbfox1 exist, but they have not been evaluated for aggressive behavior: 
a knockdown of rbfox1 in zebrafish was investigated for heart phenotypes and was shown to 
produce cardiac dysfunction and heart failure (Frese et al., 2015); knockout mice for Rbfox1 (−/−), 
central nervous system-specific, have been reported to present seizures and increased neuronal 
excitability (Gehman et al., 2011). Electrophysiological recordings of rat cortical neurons with 
increased expression of this gene also showed increased neuronal activity (Wen et al., 2015). A 
very recent study shows that RBFOX1 plays an important role in coordinating the synaptic 
downscaling of excitatory synapses (Rajman et al., 2017). Previous studies have reported that both 
excitatory and inhibitory neurotransmission are altered in aggression and that changes in neuronal 
excitation or inhibition modify aggressive behavior (Ende et al., 2015; Lin et al., 2011; Luque et 
al., 2009; Takahashi et al., 2015; Vekovischeva et al., 2004). Also, RBFOX1 is highly expressed 
in GABAergic neurons of the developing forebrain in mice (Hammock and Levitt, 2011). Thus, 
since changes in RBFOX1 seem to affect neuronal excitability, we could hypothesize that it may 
contribute to aggressive behavior by triggering alterations in inhibition/excitability balance, 
although no direct evidence of this has been observed so far. Further studies assessing aggressive 
behavior in knockout and knockin animals for Rbfox1 are required to confirm this hypothesis and 
the role of this gene in this complex phenotype. 
 
4. RBFOX1 and psychiatric neurodevelopmental and neurodegenerative disorders 
Genetic variation in RBFOX1 – both common and rare - has been associated with anxiety disorder, 
substance use disorders, schizophrenia, bipolar disorder, attentiondeficit/hyperactivity disorder 
(ADHD), autism spectrum disorder (ASD) as well as Alzheimer disease. All these disorders 
present with aggressive behaviors (Brady et al., 1998; Bubier and Drabick, 2009; Fitzpatrick et al., 
2016; Granic, 2014; Hoaken and Stewart, 2003; King and Waschbusch, 2010; Látalová, 2009; 
Volavka, 2013; Zhao et al., 2016). 
Findings for associations with common variants in the gene originate mainly from GWAS. In 
anxiety disorder, a variant in intron 1 of the RBFOX1 gene (rs13334105) showed a genome-wide 
significant association with sensitivity to anxiety. Several other SNPs within the same intron also 
showed suggestive associations (p < 1e −07) (Davies et al., 2015). The authors also inspected this 
region in a GWAS metaanalysis of anxiety disorder and observed several nominal associations. 
RBFOX1 variants have been found associated with substance dependence and the ability to quit 
smoking in 13 different datasets (reviewed by Zhong et al. (2015)). Also, several genetic markers 
in a genomic region containing RBFOX1 displayed suggestive linkage to substance dependence-
related phenotypes (Zhong et al., 2015). For schizophrenia, suggestive associations were found 
with RBFOX1 in Ashkenazi Jews (Goes et al., 2015). Also, suggestive signals in this gene were 
found associated with both Schizophrenia and bipolar disorder (Wang et al., 2010). In Alzheimer 
disease, genome-wide significant signals have been identified in the gene (Herold et al., 201 ). 
Alzheimer Disease presents a high occurrence of aggression, estimated to occur in around 40% of 
individuals with this disorder (Zhao et al., 2016). 
Using the Ricopili web tool (https://data.broadinstitute. org/mpg/ricopili/) we identified additional 
common genetic variants in RBFOX1 that show suggestive association with several psychiatric 
phenotypes: bipolar disorder and schizophrenia (cross-disorder meta-analysis; rs12444931, p = 5e 
−06), schizophrenia (rs12447542, p = 1.1e −06), smoking behavior (rs3112740, p = 6e −06) and 
number of cigarettes per day (rs8055842, p = 3.4e −05). Evidence for rare RBFOX1 variants being 
linked to brain disease come from several study designs. Copy number variants (CNVs) spanning 
the RBFOX1 gene have been reported in individuals with several psychiatric disorders. A partial 
duplication of RBFOX1 was associated with risk for schizophrenia, with an estimated eight-fold 
increased risk for males, but not for females (Melhem et al., 2011). Another partial duplication 
was identified in another patient with schizophrenia (Xu et al., 2008). A gain CNV spanning the 
first two exons of RBFOX1 and a loss in an intronic region have been reported for bipolar disorder 
(Noor et al., 2014). Also, hemizygous intronic RBFOX1 deletions and a duplication were identified 
in ADHD patients (Elia et al., 2010).  
Another study identified CNVs in RBFOX1 in patients with neuropsychiatric and 
neurodevelopmental disorders such as ASD and global developmental delay, many of them 
presenting also with epilepsy (Zhao, 2013). Interestingly, in this study, one patient with intellectual 
disability, marked aggressive behavior, and epilepsy was found to bear a deletion in the RBFOX1 
gene. Other studies identified deletions in RBFOX1 in autistic patients (Davis et al., 2012; 
Griswold et al., 2012; Martin et al., 2007; Sebat et al., 2007). One of these studies characterized a 
deletion in a proband with autism, global developmental delay, and epilepsy. The deletion was 
located at the boundary between the first exon and intron and reduced RBFOX1 mRNA expression 
in lymphocytes from the subject (Martin et al., 2007). More evidence connects RBFOX1 with 
ASD. A de novo truncating mutation in this gene and a duplication were identified in autistic 
patients (Griswold et al., 2015; Kanduri et al., 2016). A transcriptomic analysis of post-mortem 
autistic brains identified a module of co-expressed genes in which RBFOX1 was an important node 
(Voineagu et al., 2011). This gene module was enriched for associated genetic variants in an autism 
GWAS dataset. Furthermore, the authors performed RNAseq to compare brain samples of autistic 
patients with decreased expression of RBFOX1 (FC = −5.9) and controls with average expression 
of this gene, and observed a broad dysregulation of alternative splicing in the brain of autistic 
patients that is dependent on RBFOX1 . 
Several genetic alterations in RBFOX1 have been identified in individuals with epilepsy, a 
neurological disorder that has also been related to aggressive behavior (Brodie et al., 2016). In line 
with this, as mentioned above, the knockout mice for Rbfox1 show susceptibility to seizures and 
increased neuronal excitability (Gehman et al., 2011). Another study observed upregulation of 
RBFOX1 in patients with malformed cortex and epilepsy, and showed that this upregulation 
produces an increase in the neuronal activity of rat cortical neurons (Wen et al., 2015). 
The fact that RBFOX1 has been related to many psychiatric disorders make it an appealing 
candidate gene for aggression, although the increased incidence of aggression in many of these 
disorders does not connect RBFOX1 with aggressive behavior. In this regard, exploration of large 
cohorts of aggression is needed to investigate the effect of genetic variants in RBFOX1 that have 
been reported as risk factors for other psychiatric disorders. Also, we need to get more insight into 
the contribution to aggression of CNVs spanning RBFOX1 . 
 
5. Discussion and future perspectives 
In this review, we bring together different lines of evidence that implicate RBFOX1 in the etiology 
of aggressive behavior, including genetic association and mutation studies, neuroimaging genetics 
data, transcriptomic analyses, and animal models. Although the convergence of evidence is 
impressive, most of this supportive data is of nominal significance in the individual studies and 
should therefore be interpreted with caution. 
Four independent GWASs (one of them including nine datasets) associated RBFOX1 with 
aggression. However, it should be noted that this gene spans a wide region in the genome (1.7 
Mbp, more than 30 times the average length of a human gene) and carries many common variants, 
increasing the probability for identifying spurious associations. Speaking against such false 
positive effects, according to the GWAS catalog ( https://www.ebi.ac.uk/gwas/ ), so far only very 
few disease or trait associations have been identified for RBFOX1 with p -values < 1e −05, 
(including obesity and body mass index, heart rate, periodontitis, and eye related diseases). In any 
case, we cannot discard that gene length may influence the appearance of false positive 
associations. Finally, given the high degree of phenotypic heterogeneity of aggressive behaviors, 
association studies in larger and more homogeneous samples are required to confirm the 
involvement of RBFOX1 . 
All the RBFOX1 variants identified by the different GWASs of aggression lie in the first three 
introns of the gene. This localization also applies to the SNPs and CNVs associated with other 
psychiatric disorders. This clustering of risk variants may be due to the presence of regulatory 
elements of RBFOX1 in this region , as suggested by others ( Martin et al., 2007 ). To our 
knowledge, CNVs in RBFOX1 have not been investigated in relation to aggressive behavior 
directly. Such studies may be informative as they have been for schizophrenia, bipolar disorder, 
ADHD or autism. 
The neuroimaging genetics studies reported here highlight structural and functional brain 
alterations correlating with RBFOX1 variation, both in population-based cohorts and in clinical 
samples. These results point to the temporal lobe and to alterations in neurocognitive performance. 
However, to our knowledge, no investigations have been performed in clinical samples with 
pathological levels of aggression (e.g., conduct disorder, antisocial personality disorder, 
intermittent explosive disorder). Such studies may shed light on the functional significance of 
RBFOX1 with regard to brain regions previously linked to aggressive behavior, such as the 
temporal and frontal lobes, the basal ganglia and the amygdala, where the gene is highly expressed. 
Animal models can provide more insights into the role of this gene in aggression. The data from 
Drosophila reviewed above are convincing. In this regard (and given the Drosophila phenotype as 
well as the findings of duplications in the gene in human brain disorders), it might be interesting 
to assess aggressive behavior not only in knockout animals for RBFOX1 , but also in knockin 
animals, where the gene is upregulated. 
Taken together, evidence from complementary study designs point to RBFOX1 as a strong 
candidate for susceptibility to aggressive behavior and to several psychiatric disorders. Still, 
further association and neuroimaging genetics studies in larger samples, as well as studies in 
transgenic animals for RBFOX1 , are needed to confirm the contribution of this gene to aggression. 
If confirmation is obtained, RBFOX1 could be a promising pharmacological target for the 
treatment of aggression, given its broad role in the development and functioning of brain processes. 
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